IJCM  Vol.5 No.17 , September 2014
Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches
Abstract: Objective: To review presentation, diagnosis, treatment and prognosis of male breast cancer. Method: A systematic review of the English language literature between 1990 and 2013 was conducted to identify studies relevant to the objective. Searches were carried out on the database PubMed, by using the title term “male breast cancer”. Results: The majority of male patients present with a painless, firm, subareolar lump. Experience of male breast imaging is good but limited. However, there is no definitive therapeutic algorithm. Men are often treated with mastectomy instead of breast conserving surgery and mostly tamoxifen is used as an adjuvant therapy. The most important prognostic factors are tumor size and lymph node status in the armpit. Conclusion: More increased awareness and further research are needed to improve the diagnosis and treatment of this disease.
Cite this paper: Darkeh, M. and Azavedo, E. (2014) Male Breast Cancer Clinical Features, Risk Factors, and Current Diagnostic and Therapeutic Approaches. International Journal of Clinical Medicine, 5, 1068-1086. doi: 10.4236/ijcm.2014.517138.

[1]   Cutuli, B. (2007) Strategies in Treating Male Breast Cancer. Expert Opinion on Pharmacotherapy, 8, 193-202.

[2]   Gennari, R., et al. (2004) Male Breast Cancer: A Special Therapeutic Problem. Anything New? (Review). International Journal of Oncology, 24, 663-670.

[3]   Fentiman, I.S., et al. (2006) Male Breast Cancer. The Lancet, 367, 595-604.

[4]   Jamal, S., Mamoon, N., Mushtaq, S., et al. (2006) Carcinoma of the Male Breast: A Study of 141 Cases from Northern Pakistan. Asian Pacific Journal of Cancer Prevention, 7, 119-121.

[5]   Yoney, A., Kucuk, A. and Unsal, M. (2009) Male Breast Cancer: A Retrospective Analysis. Cancer/Radiothérapie, 13, 103-107.

[6]   Donegan, W.L. and Redlich, P.N. (1996) Breast Cancer in Men. Surgical Clinics of North America, 76, 343-363.

[7]   Crichlow, R.W. and Galt, S.W. (1990) Male Breast Cancer. Surgical Clinics of North America, 70, 1165-1177.

[8]   Burga, A.M., Fadare, O., Lininger, R.A., et al. (2006) Invasive Carcinomas of the Male Breast: A Morphologic Study of the Distribution of Histologic Subtypes and Metastatic Patterns in 778 Cases. Virchows Archiv, 449, 507-512.

[9]   Weiss, J.R., et al. (2005) Epidemiology of Male Breast Cancer. Cancer Epidemiology, Biomarkers Prevention, 14, 20-26.

[10]   Donegan, W.L., et al. (1998) Carcinoma of the Breast in Males: A Multiinstitutional Survey. Cancer, 83, 498-509.<498::AID-CNCR19>3.0.CO;2-R

[11]   Ravandi-Kashani, F. and Hayes, T.G. (1998) Male Breast Cancer: A Review of the Literature. European Journal of Cancer, 34, 1341-1347.

[12]   Giordano, S.H., Buzdar, A.U. and Hortobagyi, G.N. (2002) Breast Cancer in Men. Annals of Internal Medicine, 137, 678-687.

[13]   Agrawal, A., Ayantunde, A.A., Rampaul, R. and Robertson, J.F. (2007) Male Breast Cancer: A Review of Clinical Management. Breast Cancer Research and Treatment, 103, 11-21.

[14]   Borgen, P.I., Wong, G.Y., Vlamis, V., Potter, C., Hoffmann, B., Kinne, D.W., Osborne, M.P. and Mckinnon, W. (1992) Current Management of Male Breast Cancer. A Review of 104 Cases. Annals of Surgery, 215, 451.

[15]   Willsher, P.C., Leach, I.H., Ellis, I.O., Bell, J.A., Elston, C.W., Bourke, J.B., Blamey, R.W. and Robertson, J.F.R. (1997) Male Breast Cancer: Pathological and Immunohistochemical Features. Anticancer Research, 17, 2335-2338.

[16]   Sandler, B., Carman, C. and Perry, R.R. (1994) Cancer of the Male Breast. American Surgeon, 60, 816-820.

[17]   Shukla, N.K., Seenu, V., Goel, A.K., Raina, V., Rath, G.K., Singh, R., Kriplani, A.K., Deo, S.V. and Misra, M.C. (1996) Male Breast Cancer: A Retrospective Study from a Regional Cancer Center in Northern India. Journal of Surgical Oncology, 61, 143-148.<143::AID-JSO10>3.0.CO;2-A

[18]   Hassan, I. and Mabogunje, O. (1995) Cancer of the Male Breast in Zaria, Nigeria. East African Medical Journal, 72, 457-458.

[19]   Rudlowski, C. (2008) Male Breast Cancer. Breast Care, 3, 183-189.

[20]   Borgen, P.I. (1991) Male Breast Cancer. Seminars in Surgical Oncology, 7, 314-319.

[21]   Ciatto, S., Iossa, A., Bonardi, R. and Pacini, P. (1990) Male Breast Carcinoma: Review of a Multicenter Series of 150 Cases. Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer), Italy. Tumori, 76, 555-558.

[22]   Teo, J.Y., Tan, P.H. and Yong, W.S. (2012) Male Breast Cancer in Singapore: 15 Years of Experience at a Single Tertiary Institution. Annals of the Academy of Medicine, Singapore, 41, 247-251.

[23]   Shah, S., Bhattacharyya, S., Gupta, A., Ghosh, A. and Basak, S. (2012) Male Breast Cancer: A Clinicopathologic Study of 42 Patients in Eastern India. Indian Journal of Surgical Oncology, 3, 245-249.

[24]   Eryilmaz, M.A., Igci, A., Muslumanoglu, M., Ozmen, V. and Koc, M. (2012) Male Breast Cancer: A Retrospective Study of 15 Years. Journal of Balkan Union of Oncology, 17, 51-56.

[25]   Salehi, A., Zeraati, H., Mohammad, K., Mahmoudi, M., Talei, A.R., Ghaderi, A., Imanieh, M.H. and Fotouhi, A. (2011) Survival of Male Breast Cancer in Fars, South of Iran. Iranian Red Crescent Medical Journal, 13, 99-105.

[26]   Bourhafour, M., Belbaraka, R., Souadka, A., M’rabti, H., Tijami, F. and Errihani, H. (2011) Male Breast Cancer: A Report of 127 Cases at a Moroccan Institution. BMC Research Notes, 4, 219.

[27]   Liukkonen, S., Saarto, T., Maenpaa, H. and Sjöström-Mattson, J. (2010) Male Breast Cancer: A Survey at the Helsinki University Central Hospital during 1981-2006. Acta Oncologica, 49, 322-327.

[28]   Di Benedetto, G., Pierangeli, M. and Bertani, A. (1998) Carcinoma of the Male Breast: An Underestimated Killer. Plastic & Reconstructive Surgery, 102, 696-700.

[29]   Ngoo, K.S., Rohaizak, M., Naqiyah, I. and Shahrun Niza, A.S. (2009) Male Breast Cancer: Experience from a Malaysian Tertiary Centre. Singapore Medical Journal, 50, 519-521.

[30]   Kidmas, A.T., Ugwu, B.T., Manasseh, A.N., Iya, D. and Opaluwa, A.S. (2005) Male Breast Malignancy in Jos University Teaching Hospital. West African Journal of Medicine, 24, 36-40.

[31]   Giordano, S.H., Cohen, D.S., Buzdar, A.U., Perkins, G. and Hortobagyi, G.N. (2004) Breast Carcinoma in Men: A Population-Based Study. Cancer, 101, 51-57.

[32]   El Omari-Alaoui, H., Lahdiri, I., Nejjar, I., Hadadi, K., Ahyoud, F., Hachi, H., et al. (2002) Male Breast Cancer. A Report of 71 Cases. Cancer/Radiothérapie, 6, 349-351.

[33]   Chantra, P.K., So, G.J., Wollman, J.S. and Bassett, L.W. (1995) Mammography of the Male Breast. American Journal of Roentgenology, 164, 853-858.

[34]   O’Hanlon, D.M., Kent, P., Kerin, M.J. and Given, H.F. (1995) Unilateral Breast Masses in Men over 40: A Diagnostic Dilemma. American Journal of Surgery, 170, 24-26.

[35]   Jamal, S., et al. (1994) Malignant Tumors of the Male Breast—A Review of 50 Cases. Journal of Pakistan Medical Association, 44, 275-277.

[36]   Gough, D.B., Donohue, J.H., Evans, M.M., Pernicone, P.J., Wold, L.E., Naessens, J.M. and O’Brien, P.C. (1993) A 50-Year Experience of Male Breast Cancer: Is Outcome Changing? Surgical Oncology, 2, 325-333.

[37]   Dershaw, D.D., Borgen, P.I., Deutch, B.M. and Liberman, L. (1993) Mammographic Findings in Men with Breast Cancer. American Journal of Roentgenology, 160, 267-270.

[38]   Stierer, M., Rosen, H., Weitensfelder, W., Hausmaninger, H., Teleky, B., Jakesz, R., et al. (1995) Male Breast Cancer: Austrian Experience. World Journal of Surgery, 19, 687-692.

[39]   Mathew, J., Perkins, G.H., Stephens, T., Middleton, L.P. and Yang, W.T. (2008) Primary Breast Cancer in Men: Clinical, Imaging, and Pathologic Findings in 57 Patients. American Journal of Roentgenology, 191, 1631-1639.

[40]   Joshi, M.G., Lee, A.K.C., Loda, M., Camus, M.G., Pedersen, C., Heatley, G.J. and Hughes, K.S. (1996) Male Breast Carcinoma: An Evaluation of Prognostic Factors Contributing to a Poorer Outcome. Cancer, 77, 490-498.<490::AID-CNCR10>3.0.CO;2-#

[41]   Onami, S., Ozaki, M., Mortimer, J.E. and Pal, S.K. (2010) Male Breast Cancer: An Update in Diagnosis, Treatment and Molecular Profiling. Maturitas, 65, 308-314.

[42]   Muñoz Carrasco, R., álvarez Benito, M. and del Campo, E.R. (2013) Value of Mammography and Breast Ultrasound in Male Patients with Nipple Discharge. European Journal of Radiology, 82, 478-484.

[43]   Tural, D., Selçukbiricik, F., Aydogan, F., Bese, N., Yetmen, Ö., Ilvan, S., Büyükünal, E. and Serdengeçti, S. (2013) Male Breast Cancers Behave Differently in Elderly Patients. Japanese Journal of Clinical Oncology, 43, 22-27.

[44]   Iuanow, E., Kettler, M. and Slanetz, P.J. (2011) Spectrum of Disease in the Male Breast. American Journal of Roentgenology, 196, W247-W259.

[45]   Adibelli, Z.H., Oztekin, O., Postaci, H. and Uslu, A. (2009) The Diagnostic Accuracy of Mammography and Ultrasound in the Evaluation of Male Breast Disease: A New Algorithm. Breast Care, 4, 255-259.

[46]   Lattin Jr., G.E., Jesinger, R.A., Mattu, R. and Glassman, L.M. (2013) From the Radiologic Pathology Archives: Diseases of the Male Breast: Radiologic-Pathologic Correlation. Radio-Graphics, 33, 461-489.

[47]   Hines, S.L., Tan, W.W., Yasrebi, M., Deperi, E.R. and Perez, E.A. (2007) The Role of Mammography in Male Patients with Breast Symptoms. Mayo Clinic Proceedings, 82, 297-300.

[48]   Günhan-Bilgen, I., Bozkaya, H., üstün, E.E. and Memis, A. (2002) Male Breast Disease: Clinical, Mammographic, and Ultrasonographic Features. European Journal of Radiology, 43, 246-255.

[49]   Cooper, R.A., Gunter, B.A. and Ramamurthy, L. (1994) Mammography in Men. Radiology, 191, 651-656.

[50]   Evans, G.F.F., Anthony, T., Appelbaum, A.H., Schumpert, T.D., Levy, K.R., Amirkhan, R.H., Cambell, T.J., Lopez, J. and Turnage, R.H. (2001) The Diagnostic Accuracy of Mammography in the Evaluation of Male Breast Disease. American Journal of Surgery, 181, 96-100.

[51]   Williams, W.L. Jr., Powers, M. and Wagman, L.D. (1996) Cancer of the Male Breast: A Review. Journal of the National Medical Association, 88, 439-442.

[52]   Volpe, C.M., Raffetto, J.D., Collure, D.W., Hoover, E.L. and Doerr, R.J. (1999) Unilateral Male Breast Masses: Cancer Risk and Their Evaluation and Management. American Surgeon, 65, 250-253.

[53]   Yitta, S., Singer, C.I., Toth, H.B. and Mercado, C.L. (2010) Image Presentation. Sonographic Appearances of Benign and Malignant Male Breast Disease with Mammographic and Pathologic Correlation. Journal of Ultrasound in Medicine, 29, 931-947.

[54]   Bazzocchi, M., Vianello, E., Linda, A., Londero, V. and Zuiani, C. (2010) Male Breast Lesions: Which Abnormalities Really Need Core Needle Biopsy? Tumori, 96, 266-270.

[55]   Chen, L., Chantra, P.K., Larsen, L.H., Barton, P., Rohitopakarn, M., Zhu, E.Q. and Bassett, L.W. (2006) Imaging Characteristics of Malignant Lesions of the Male Breast. RadioGraphics, 26, 993-1006.

[56]   Hines, S.L., Tan, W., Larson, J.M., Thompson, K.M., Jorn, H.K. and Files, J.A. (2008) A Practical Approach to Guide Clinicians in the Evaluation of Male Patients with Breast Masses. Geriatrics, 63, 19-24.

[57]   Korde, L.A., Zujewski, J.A., Kamin, L., Giordano, S., Domchek, S., Anderson, W.F., et al. (2010) Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations. Journal of Clinical Oncology, 28, 2114-2122.

[58]   Hanavadi, S., Monypenny, I.J. and Mansel, R.E. (2006) Is Mammography Overused in Male Patients? The Breast, 15, 123-126.

[59]   Applebaum, A.H., Evans, G.F., Levy, K.R., Amirkhan, R.H. and Schumpert, T.D. (1999) Mammographic Appearances of Male Breast Disease. RadioGraphics, 19, 559-568.

[60]   Draghi, F., Tarantino, C.C., Madonia, L. and Ferrozzi, G. (2011) Ultrasonography of the Male Breast. Journal of Ultrasound, 14, 122-129.

[61]   Reis, L.O., Gf Dias, F., As Castro, M. and Ferreira, U. (2011) Male Breast Cancer. Aging Male, 14, 99-109.

[62]   Yang, W.T., Whitman, G.J., Yuen, E.H.Y., Tse, G.M.K. and Stelling, C.B. (2001) Sonographic Features of Primary Breast Cancer in Men. American Journal of Roentgenology, 176, 413-416.

[63]   Stewart, R.A., Howlett, D.C. and Hearn, F.J. (1997) Pictorial Review: The Imaging Features of Male Breast Disease. Clinical Radiology, 52, 739-744.

[64]   Charlot, M., Béatrix, O., Chateau, F., Dubuisson, J., Golfier, F., Valette, P.J. and Réty, F. (2013) Pathologies of the Male Breast. Diagnostic and Interventional Imaging, 94, 26-37.

[65]   Adibelli, Z.H., Oztekin, O., Gunhan-Bilgen, I., Postaci, H., Uslu, A. and Ilhan, E. (2010) Imaging Characteristics of Male Breast Disease. Breast Journal, 16, 510-518.

[66]   Patterson, S.K., Helvie, M.A., Aziz, K. and Nees, A.V. (2006) Outcome of Men Presenting with Clinical Breast Problems: The Role of Mammography and Ultrasound. Breast Journal, 12, 418-423.

[67]   Taylor, K., Ames, V. and Wallis, M. (2013) The Diagnostic Value of Clinical Examination and Imaging Used as Part of an Age-Related Protocol When Diagnosing Male Breast Disease: An Audit of 1141 Cases from a Single Centre. Breast, 22, 268-272.

[68]   Morrogh, M. and King, T.A. (2009) The Significance of Nipple Discharge of the Male Breast. Breast Journal, 15, 632-638.

[69]   Vetto, J., Schmidt, W., Pommier, R., Ditomasso, J., Eppich, H., Wood, W. and Moseson, D. (1998) Accurate and Cost-Effective Evaluation of Breast Masses in Males. American Journal of Surgery, 175, 383-387.

[70]   Fentiman, I.S. (2009) Male Breast Cancer: A Review. Ecancermedicalscience, 3, 140.

[71]   Rosen, D.G., Laucirica, R. and Verstovsek, G. (2009) Fine Needle Aspiration of Male Breast Lesions. Acta Cytologica, 53, 369-374.

[72]   Westenend, P.J. and Jobse, C. (2002) Evaluation of Fine-Needle Aspiration Cytology of Breast Masses in Males. Cancer, 96, 101-104.

[73]   Lilleng, R., Paksoy, N., Vural, G., Langmark, F. and Hagmar, B. (1995) Assessment of Fine Needle Aspiration Cytology and Histopathology for Diagnosing Male Breast Masses. Acta Cytologica, 39, 877-881.

[74]   Das, D.K., Junaid, T.A., Mathews, S.B., Ajrawi, T.G., Ahmed, M.S., Madda, J.P. and Mirza, K. (1995) Fine Needle Aspiration Cytology Diagnosis of Male Breast Lesions. A Study of 185 Cases. Acta Cytologica, 39, 870-876.

[75]   Sneige, N., Holder, P.D., Katz, R.L., Fanning, C.V., Dekmezian, R.H., Shabb, N.S. and Singletary, S.E. (1993) Fine-Needle Aspiration Cytology of the Male Breast in a Cancer Center. Diagnostic Cytopathology, 9, 691-697.

[76]   Gupta, R.K., Naran, S., Dowle, C.S. and Simpson, J.S. (1991) The Diagnostic Impact of Needle Aspiration Cytology of the Breast on Clinical Decision Making with an Emphasis on the Aspiration Cytodiagnosis of the Male Breast. Diagnostic Cytopathology, 7, 637-639.

[77]   Westenend, P.J. (2003) Core Needle Biopsy in Male Breast Lesions. Journal of Clinical Pathology, 56, 863-865.

[78]   Zhou, F.F., Xia, L.P., Guo, G.F., Wang, X., Yuan, Z.Y., Zhang, B. and Wang, F. (2010) Changes in Therapeutic Strategies in Chinese Male Patients with Breast Cancer: 40 Years of Experience in a Single Institute. Breast, 19, 450-455.

[79]   Contractor, K.B., Kaur, K., Rodrigues, G.S., Kulkarni, D.M. and Singhal, H. (2008) Male Breast Cancer: Is the Scenario Changing. World Journal of Surgical Oncology, 6, 58.

[80]   La Pinta, M., Fabi, A., Ascarelli, A., Ponzani, T., Di Carlo, V., Scicchitano, F., Saputo, S., Russillo, M. and Andrich, R. (2008) Male Breast Cancer: 6-Year Experience. Minerva Chirurgica, 63, 71-78.

[81]   Atalay, C., Kanlioz, M. and Altinok, M. (2003) Prognostic Factors Affecting Survival in Male Breast Cancer. Journal of Experimental & Clinical Cancer Research, 22, 29-33.

[82]   Zhou, F.F., Xia, L.P., Wang, X., Guo, G.F., Rong, Y.M., Qiu, H.J. and Zhang, B. (2010) Analysis of Prognostic Factors in Male Breast Cancer: A Report of 72 Cases from a Single Institution. Chinese Journal of Cancer, 29, 184-188.

[83]   Goss, P.E., Reid, C., Pintilie, M., Lim, R. and Miller, N. (1999) Male Breast Carcinoma: A Review of 229 Patients Who Presented to the Princess Margaret Hospital during 40 Years: 1955-1996. Cancer, 85, 629-639.<629::AID-CNCR13>3.0.CO;2-V

[84]   El-Tamer, M.B., Komenaka, I.K., Troxel, A., Li, H.L., Joseph, K.A., Ditkoff, B.A., Schnabel, F.R. and Kinne, D.W. (2004) Men with Breast Cancer Have Better Disease-Specific Survival than Women. JAMA Surgery, 139, 1079-1082.

[85]   Margaria, E., Chiusa, L., Ferrari, L., Dal Canton, O. and Pich, A. (2000) Therapy and Survival in Male Breast Carcinoma: A Retrospective Analysis of 50 Cases. Oncology Reports, 7, 1035-1039.

[86]   Ribeiro, G., Swindell, R., Harris, M., Banerjee, S.S. and Cramer, A. (1996) A Review of the Management of the Male Breast Carcinoma Based on an Analysis of 420 Treated Cases. Breast, 5, 141-146.

[87]   Cutuli, B., Lacroze, M., Dilhuydy, J.M., Veiten, M., De Lafontan, B., Marchal, C., Resbeut, M., et al. (1995) Male Breast Cancer: Results of the Treatments and Prognostic Factors in 397 Cases. European Journal of Cancer, 31, 1960-1964.

[88]   Zygogianni, A.G., Kyrgias, G., Gennatas, C., Ilknur, A., Armonis, V., Tolia, M., et al. (2012) Male Breast Carcinoma: Epidemiology, Risk Factors and Current Therapeutic Approaches. Asian Pacific Journal of Cancer Prevention, 13, 15-19.

[89]   Schaub, N.P., Maloney, N., Schneider, H., Feliberti, E. and Perry, R. (2008) Changes in Male Breast Cancer over a 30-Year Period. The American Surgeon, 74, 707-712.

[90]   Scott-Conner, C.E., Jochimsen, P.R., Menck, H.R. and Winchester, D.J. (1999) An Analysis of Male and Female Breast Cancer Treatment and Survival among Demographically Identical Pairs of Patients. Surgery, 126, 775-780, Discussion 780-771.

[91]   Vinod, S.K. and Pendlebury, S.C. (1999) Carcinoma of the Male Breast: A Review of Adjuvant Therapy. Australasian Radiology, 43, 69-72.

[92]   Gómez-Raposo, C., Tévar, F.Z., Moyano, M.S., Gómez, M.L. and Casado, E. (2010) Male Breast Cancer. Cancer Treatment Reviews, 36, 451-457.

[93]   Selcukbiricik, F., Tural, D., Aydogan, F., Bese, N., Büyükünal, E. and Serdengeçti, S. (2013) Male Breast Cancer: 37-Year Data Study at a Single Experience Center in Turkey. Journal of Breast Cancer, 16, 60-65.

[94]   Giordano, S.H., Perkins, G.H., Broglio, K., Garcia, S.G., Middleto, L.P., Buzdar, A.U. and Hortobagyi, G.N. (2005) Adjuvant Systemic Therapy for Male Breast Carcinoma. Cancer, 104, 2359-2364.

[95]   Ruddy, K.J. and Winer, E.P. (2013) Male Breast Cancer: Risk Factors, Biology, Diagnosis, Treatment, and Survivorship. Annals of Oncology, 24, 1434-1443.

[96]   Cloyd, J.M., Hernandez-Boussard, T. and Wapnir, I.L. (2013) Outcomes of Partial Mastectomy in Male Breast Cancer Patients: Analysis of SEER, 1983-2009. Annals of Surgical Oncology, 20, 1545-1550.

[97]   Pant, K. and Dutta, U. (2008) Understanding and Management of Male Breast Cancer: A Critical Review. Medical Oncology, 25, 294-298.

[98]   Yildirim, E. and Berberoglu, U. (1998) Male Breast Cancer: A 22-Year Experience. European Journal of Surgical Oncology, 24, 548-552.

[99]   Flynn, L.W., Park, J., Patil, S.M., Cody, H.S. and Port, E.R. (2008) Sentinel Lymph Node Biopsy Is Successful and Accurate in Male Breast Carcinoma. Journal of the American College of Surgeons, 206, 616-621.

[100]   Gentilini, O., Chagas, E., Zurrida, S., Intra, M., De Cicco, C. and Gatti, G. (2007) Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer. Oncologist, 12, 512-515.

[101]   Rusby, J.E., Smith, B.L., Dominguez, F.J. and Golshan, M. (2006) Sentinel Lymph Node Biopsy in Men with Breast Cancer: A Report of 31 Consecutive Procedures and Review of Literature. Clinical Breast Cancer, 7, 406-410.

[102]   Boughey, J.C., Bedrosian, I., Meric-Bernstam, F., Ross, M.I., Kuerer, H.M., Akins, J.S., et al. (2006) Comparative Analysis of Sentinel Lymph Node Operation in Male and Female Breast Cancer Patients. Journal of the American College of Surgeons, 203, 475-480.

[103]   De Cicco, C., Baio, S.M., Veronesi, P., et al. (2004) Sentinel Node Biopsy in Male Breast Cancer. Nuclear Medicine Communications, 25, 139-143.

[104]   Goyal, A., Horgan, K., Kissin, M., Yiangou, C., Sibbering, M., Lansdown, M., Newcombe, R.G. and Mansel, R.E. (2004) Sentinel Lymph Node Biopsy in Male Breast Cancer Patients. European Journal of Surgical Oncology, 30, 480-483.

[105]   Cimmino, V.M., Degnim, A.C., Sabel, M.S., Diehl, K.M., Newman, L.A. and Chang, A.E. (2004) Efficacy of Sentinel Lymph Node Biopsy in Male Breast Cancer. Journal of Surgical Oncology, 86, 74-77.

[106]   Albo, D., Ames, F.C., Hunt, K.K., Ross, M.I., Singletary, S.E. and Kuerer, H.M. (2003) Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy. Breast Cancer Research and Treatment, 77, 9-14.

[107]   Port, E.R., Fey, J.V., Cody III, H.S. and Borgen, P.I. (2001) Sentinel Lymph Node Biopsy in Patients with Male Breast Carcinoma. Cancer, 91, 319-323.<319::AID-CNCR1004>3.0.CO;2-D

[108]   Bratman, S.V., Kapp, D.S. and Horst, K.C. (2012) Evolving Trends in the Initial Locoregional Management of Male Breast Cancer. Breast, 21, 296-302.

[109]   Chakravarthy, A. and Kim, C.R. (2002) Post-Mastectomy Radiation in Male Breast Cancer. Radiotherapy and Oncology, 65, 99-103.

[110]   De Los Santos, J.F. and Buchholz, T.A. (2000) Carcinoma of the Male Breast. Current Treatment Options in Oncology, 1, 221-227.

[111]   Kamila, C., Jenny, B., Per, H. and Jonas, B. (2007) How to Treat Male Breast Cancer. Breast, 16, 147-154.

[112]   Cutuli, B., Cohen-Solal Le-Nir, C., Serin, D., Kirova, Y., Gaci, Z., Lemanski, C., De Lafontan, B., et al. (2010) Male Breast Cancer. Evolution of Treatment and Prognostic Factors. Analysis of 489 Cases. Critical Reviews in Oncology/Hematology, 73, 246-254.

[113]   Kinne, D.W. (1991) Management of Male Breast Cancer. Oncology (Williston Park), 5, 45-47.

[114]   Chung, H.C., Koh, E.H., Roh, J.K., Min, J.S., Lee, K.S., Suh, C.O., Kim, K.E., Loh, J.J., Lee, K.B. and Kim, B.S. (1990) Male Breast Cancer—A 20-Year Review of 16 Cases at Yonsei University. Yonsei Medical Journal, 31, 242-250.

[115]   Vetto, J., Jun, S.Y., Padduch, D., Eppich, H. and Shih, R. (1999) Stages at Presentation, Prognostic Factors, and Outcome of Breast Cancer in Males. American Journal of Surgery, 177, 379-383.

[116]   Schuchardt, U., Seegenschmiedt, M.H., Kirschner, M.J., Renner, H. and Sauer, R. (1996) Adjuvant Radiotherapy for Breast Carcinoma in Men: A 20-Year Clinical Experience. American Journal of Clinical Oncology, 19, 330-336.

[117]   Yu, E., Suzuki, H., Younus, J., Elfiki, T., Stitt, L., Yau, G., et al. (2012) The Impact of Post-Mastectomy Radiation Therapy on Male Breast Cancer Patients—A Case Series. International Journal of Radiation Oncology • Biology • Physics, 82, 696-700.

[118]   Yoney, A., Kucuk, A., Alan, O. and Unsal, M. (2008) A Retrospective Study of Treatment and Outcome in 39 Cases of Male Breast Cancer. Hematology/Oncology and Stem Cell Therapy, 1, 98-105.

[119]   Zabel, A., Milker-Zabel, S., Zuna, I., Wannenmacher, M. and Debus, J. (2005) External Beam Radiotherapy in the Treatment of Male Breast Carcinoma: Patterns of Failure in a Single Institute Experience. Tumori, 91, 151-155.

[120]   Stranzl, H., Mayer, R., Quehenberger, F., Prettenhofer, U., Willfurth, P., Stöger, H. and Hackl, A. (1999) Adjuvant Radiotherapy in Male Breast Cancer. Radiotherapy and Oncology, 53, 29-35.

[121]   Atahan, L., Yildiz, F., Selek, U., Sari, S. and Gurkaynak, M. (2006) Postoperative Radiotherapy in the Treatment of Male Breast Carcinoma: A Single Institute Experience. Journal of the National Medical Association, 98, 559-563.

[122]   Hill, A., Yagmoury, Y., Tran, K.N., Bolton, J.S., Robson, M. and Borgen, P.I. (1999) Localized Male Breast Carcinoma and Family History. An Analysis of 142 Patients. Cancer, 86, 821-825.<821::AID-CNCR18>3.0.CO;2-I

[123]   Chakravarthy, A. and Kim, C.R. (2002) Post-Mastectomy Radiation in Male Breast Cancer. Radiotherapy and Oncology, 65, 99-103.

[124]   Eggemann, H., Ignatov, A., Stabenow, R., Von Minckwitz, G., Röhl, F.W., Hass, P. and Costa, S.D. (2013) Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy Radiotherapy. Breast Care (Basel), 8, 270-275.

[125]   Akbulut, S., Arer, I., Kocbiyik, A., Can Yagmurdur, M., Karakayali, H. and Haberal, M. (2009) Male Breast Cancer: Thirteen Years’ Experience of a Single Center. International Seminars in Surgical Oncology, 6, 4.

[126]   Meguerditchian, A.N., Falardeau, M. and Martin, G. (2002) Male Breast Carcinoma. Canadian Journal of Surgery, 45, 296-302.

[127]   Jaiyesimi, I.A., Buzdar, A.U., Sahin, A.A. and Ross, M.A. (1992) Carcinoma of the Male Breast. Annals of Internal Medicine, 117, 771-777.

[128]   Izquierdo, M.A., Alonso, C., de Andres, L. and Ojeda, B. (1994) Male Breast Cancer Report of a Series of 50 Cases. Acta Oncologica, 33, 767-771.

[129]   Ying, M., Agrawal, A. and Cheung, K.L. (2005) The “Other Half” of Breast Cancer: A Review of Male Breast Cancer. Journal of Men’s Health and Gender, 2, 406-413.

[130]   Fogh, S., Hirsch, A.E., Goldberg, S.I., Rosenberg, C.L., Taghian, A.G., Powell, S.N., Kachnic, L.A. and Langmead, J.P. (2011) Use of Tamoxifen with Postsurgical Irradiation May Improve Survival in Estrogen and Progesterone Receptor-Positive Male Breast Cancer. Clinical Breast Cancer, 11, 39-45.

[131]   Ribeiro, G. and Swindell, R. (1992) Adjuvant Tamoxifen for Male Breast Cancer (MBC). British Journal of Cancer, 65, 252-254.

[132]   Wang-Rodriguez, J., Cross, K., Gallagher, S., Djahanban, M., Armstrong, J.M., Wiedner, N. and Shapiro, D.H. (2002) Male Breast Cancer: Correlation of ER, PR, Ki-67, HER2/Neu and P53 with Treatment and Survival, a Study of 65 Cases. Modern Pathology, 15, 853-861.

[133]   Pich, A., Margaria, E., Chiusa, L., Candelaresi, G. and Dal Canton, O. (1999) Androgen Receptor Expression in Male Breast Carcinoma: Lack of Clinicopathological Association. British Journal of Cancer, 79, 959-964.

[134]   Pich, A., Margaria, E. and Chiusa, L. (1994) Proliferative Activity Is a Significant Prognostic Factor in Male Breast Carcinoma. American Journal of Pathology, 145, 481-489.

[135]   Xu, S., Yang, Y., Tao, W., Song, Y., Chen, Y., Ren, Y., Liu, J. and Pang, D. (2012) Tamoxifen Adherence and Its Relationship to Mortality in 116 Men with Breast Cancer. Breast Cancer Research and Treatment, 136, 495-502.

[136]   Anelli, T.F., Anelli, A., Tran, K.N., Lebwohl, D.E. and Borgen, P.I. (1994) Tamoxifen Administration Is Associated with a High Rate of Treatment-Limiting Symptoms in Male Breast Cancer Patients. Cancer, 74, 74-77.<74::AID-CNCR2820740113>3.0.CO;2-#

[137]   Pemmaraju, N., Munsell, M.F., Hortobagyi, G.N. and Giordano, S.H. (2012) Retrospective Review of Male Breast Cancer Patients: Analysis of Tamoxifen-Related Side-Effects. Annals of Oncology, 23, 1471-1474.

[138]   Visram, H., Kanji, F. and Dent, S.F. (2010) Endocrine Therapy for Male Breast Cancer: Rates of Toxicity and Adherence. Current Oncology, 17, 17-21.

[139]   Miao, H., Verkooijen, H.M., Chia, K.S., Bouchardy, C., Pukkala, E., Larønningen, S., Mellemkjær, L., Czene, K. and Hartman, M. (2011) Incidence and Outcome of Male Breast Cancer: An International Population-Based Study. Journal of Clinical Oncology, 29, 4381-4386.

[140]   Hayes, T.G. (2009) Pharmacologic Treatment of Male Breast Cancer. Expert Opinion on Pharmacotherapy, 10, 2499-2510.

[141]   Nordman, I.C. and Dalley, D.N. (2008) Breast Cancer in Men: Should Aromatase Inhibitors Become First-Line Hormonal Treatment? Breast Journal, 14, 562-569.

[142]   Hayes, T. (2002) Pharmacotherapy for Male Breast Cancer. Expert Opinion on Pharmacotherapy, 3, 701-708.

[143]   White, J., Kearins, O., Dodwell, D., Horgan, K., Hanby, A.M. and Speirs, V. (2011) Male Breast Carcinoma: Increased Awareness Needed. Breast Cancer Research, 13, 219.

[144]   Doyen, J., Italiano, A., Largillier, R., Ferrero, J.M., Fontana, X. and Thyss, A. (2010) Aromatase Inhibition in Male Breast Cancer Patients: Biological and Clinical Implications. Annals of Oncology, 21, 1243-1245.

[145]   Eggemann, H., Ignatov, A., Smith, B.J., Altmann, U., von Minckwitz, G., Röhl, F.W., Jahn, M. and Costa, S.D. (2013) Adjuvant Therapy with Tamoxifen Compared to Aromatase Inhibitors for 257 Male Breast Cancer Patients. Breast Cancer Research and Treatment, 137, 465-470.

[146]   Nahleh, Z.A. (2006) Hormonal Therapy for Male Breast Cancer: A Different Approach for a Different Disease. Cancer Treatment Reviews, 32, 101-105.

[147]   Giordano, S.H. (2005) A Review of the Diagnosis and Management of Male Breast Cancer. Oncologist, 10, 471-479.

[148]   Buzdar, A.U. (2003) Breast Cancer in Men. Oncology (Williston Park), 17, 1361-1364.

[149]   Volm, M.D. (2003) Male Breast Cancer. Current Treatment Options in Oncology, 4, 159-164.

[150]   Walshe, J.M., Berman, A.W., Vatas, U., Steinberg, S.M., Anderson, W.F., Lippman, M.E. and Swain, S.M. (2007) A Prospective Study of Adjuvant CMF in Males with Node Positive Breast Cancer: 20-Year Follow-Up. Breast Cancer Research and Treatment, 103, 177-183.

[151]   Liu, T., Tong, Z., He, L. and Zhang, L. (2011) Clinicopathological Characteristics and Survival Analysis of 87 Male Breast Cancer Cases. Breast Care (Basel), 6, 446-451.

[152]   Sulyok, Z. and Köves, I. (1993) Male Breast Tumors. European Journal of Surgical Oncology, 19, 581-586.

[153]   Nahleh, Z. and Girnius, S. (2006) Male Breast Cancer: A Gender Issue. Nature Reviews Clinical Oncology, 3, 428-437.

[154]   Wagner, J.L., Thomas Jr., C.R., Koh, W.J. and Rudolph, R.H. (1995) Carcinoma of the Male Breast: Update 1994. Medical and Pediatric Oncology, 24, 123-132.

[155]   Satram-Hoang, S., Ziogas, A. and Anton-Culver, H. (2007) Risk of Second Primary Cancer in Men with Breast Cancer. Breast Cancer Research, 9, R10.

[156]   Hemminki, K., Scélo, G., Boffetta, P., Mellemkjaer, L., Tracey, E., Andersen, A., et al. (2005) Second Primary Malignancies in Patients with Male Breast Cancer. British Journal of Cancer, 92, 1288-1292.

[157]   Auvinen, A., Curtis, R.E. and Ron, E. (2002) Risk of Subsequent Cancer Following Breast Cancer in Men. Journal of the National Cancer Institute, 94, 1330-1332.

[158]   Xia, L.P., Zhou, F.F., Guo, G.F., Wang, F., Wang, X., Yuan, Z.Y. and Zhang, B. (2010) Chinese Female Breast Cancer Patients Show a Better Overall Survival than Their Male Counterparts. Chinese Medical Journal, 123, 2347-2352.

[159]   Müller, A.C., Gani, C., Rehm, H.M.E., Eckert, F., Bamberg, M., Hehr, T. and Weinmann, M. (2012) Are There Biologic Differences between Male and Female Breast Cancer Explaining Inferior Outcome of Men Despite Equal Stage and Treatment?! Strahlentherapie und Onkologie, 188, 782-787.

[160]   Anan, K., Mitsuyama, S., Nishihara, K., Abe, Y., Iwashita, T., lhara, T., Tamae, K., Ono, M. and Toyoshima, S. (2004) Breast Cancer in Japanese Men: Does Sex Affect Prognosis? Breast Cancer, 11, 180-186.

[161]   Borgen, P.I., Senie, R.T., Mckinnon, W.M. and Rosen, P.P. (1997) Carcinoma of the Male Breast: Analysis of Prognosis Compared with Matched Female Patients. Annals of Surgical Oncology, 4, 385-388.

[162]   Willsher, P.C., Leach, I.H., Ellis, I.O., Bourke, J.B., Blamey, R.W. and Robertson, J.F. (1997) A Comparison of Outcome of Male Breast Cancer with Female Breast Cancer. The American Journal of Surgery, 173,185-188.

[163]   Guinee, V.F., Shallenberger, R.C., Olsson, H., Moller, T., van den Blink, J.W., Peter, Z., et al. (1993) The Prognosis of Breast Cancer in Males. A Report of 335 Cases. Cancer, 71, 154.<154::AID-CNCR2820710125>3.0.CO;2-#

[164]   Rossman, E., Libjegren, A. and Bergh, J. (2007) Male Breast Cancer-How to Treat? Breast Cancer Online, 10, 1-6.

[165]   Temmim, L., Luqmani, Y.A., Jarallah, M., Juma, I. and Mathew, M. (2001) Evaluation of Prognostic Factors in Male Breast Cancer. The Breast, 10, 166-175.

[166]   Bruce, D.M., Heys, S.D., Payne, S., Miller, I.D. and Eremin, O. (1996) Male Breast Cancer: Clinico-Pathological Features, Immunocytochemical Characteristics and Prognosis. European Journal of Surgical Oncology, 22, 42-46.

[167]   Salvadori, B., Saccozzi, R., Manzari, A., Andreola, S., Conti, R.A., Cusumano, F. and Grassi, M. (1994) Prognosis of Breast Cancer in Males: An Analysis of 170 Cases. European Journal of Cancer, 30, 930-935.

[168]   Kardas, I., Seitz, G., Limon, J., Niezabitowski, A., Rys, J., Theisinger, B., Welter, C. and Blin, N. (1993) Retrospective Analysis of Prognostic Significance of the Estrogen-Inducible pS2 Gene in Male Breast Carcinoma. Cancer, 72, 1652-1656.<1652::AID-CNCR2820720526>3.0.CO;2-4

[169]   Clark, J.L., Nguyen, P.L., Jaszcz, W.B., Jatoi, A. and Niehans, G.A. (2000) Prognostic Variables in Male Breast Cancer. American Surgeon, 66, 502-511.

[170]   Foerster, R., Foerster, F.G., Wulff, V., Schubotz, B., Baaske, D., Wolfgarten, M., Kuhn, W.C. and Rudlowski, C. (2011) Matched-Pair Analysis of Patients with Female and Male Breast Cancer: A Comparative Analysis. BMC Cancer, 11, 335.

[171]   Avisar, E., McParland, E., Dicostanzo, D. and Axelrod, D. (2006) Prognostic Factors in Node-Negative Male Breast Cancer. Clinical Breast Cancer, 7, 331-335.

[172]   Meattini, I., Livi, L., Franceschini, D., Saieva, C., Scotti, V., Casella, D., et al. (2013) Treatment of Invasive Male Breast Cancer: A 40-Year Single-Institution Experience. La Radiologia Medica, 118, 476-486.

[173]   Arslan, U.Y., Oksuzoglu, B., Ozdemir, N., Aksoy, S., Alkös, N., Gök, A., et al. (2012) Outcome of Non-Metastatic Male Breast Cancer: 118 Patients. Medical Oncology, 29, 554-560.

[174]   Ravi, A., Bang, H., Karsif, K. and Nori, D. (2012) Breast Cancer in Men: Prognostic Factors, Treatment Patterns, and Outcome. American Journal of Men’s Health, 6, 51-58.

[175]   De Ieso, P.B., Potter, A.E., Le, H., Luke, C. and Gowda, R.V. (2012) Male Breast Cancer: A 30-Year Experience in South Australia. Asia-Pacific Journal of Clinical Oncology, 8, 187-193.

[176]   André, S., Fonseca, I., Pinto, A.E., Cardoso, P., Pereira, T. and Soares, J. (2001) Male Breast Cancer? A Reappraisal of Clinical and Biologic Indicators of Prognosis. Acta Oncologica, 40, 472-478.

[177]   Herman, K., Lobaziewicz, W., Skotnicki, P., Fortuna, J., Kusy, T. and Lesniak, T. (2000) Male Breast Cancer. Does the Prognosis Differ Compared to Female? Neoplasma, 47, 191-195.

[178]   de Perrot, M. and Deléaval, J. (2000) Thirty-Year Experience of Surgery for Breast Carcinoma in Men. European Journal of Surgery, 166, 929-931.

[179]   Marchal, F., Salou, M., Marchal, C., Lesur, A. and Desandes, E. (2009) Men with Breast Cancer Have Same Disease-Specific and Even-Free Survival as Woman. Annals of Surgical Oncology, 16, 972-978.

[180]   Dabakuyo, T.S., Dialla, O., Gentil, J., Poillot, M.L., Roignot, P., Cuisenier, J. and Arveux, P. (2012) Breast Cancer in Men in Cote d’Or (France): Epidemiological Characteristics, Treatments and Prognostic Factors. European Journal of Cancer Care, 21, 809-816.

[181]   Thalib, L. and Hall, P. (2009) Survival of Male Breast Cancer Patients: Population-Based Cohort Study. Cancer Science, 100, 292-295.

[182]   Ulutin, C., Güden, M., Sürenkök, S. and Pak, Y. (1998) Fifteen Cases of Male Breast Carcinoma Treated between 1980 and 1995. Radiation Medicine, 16, 383-386.

[183]   Engin, K. and Unsal, M. (1993) Cancer of the Male Breast: The Turkish Experience. Journal of Surgical Oncology, 53, 128-132.

[184]   Tajima, N., Tsukuma, H. and Oshima, A. (2001) Descriptive Epidemiology of Male Breast Cancer in Osaka, Japan. Journal of Epidemiology, 11, 1-7.

[185]   Chung, H.C., Kim, D.L., Koh, E.H., Kim, J.H., Roh, J.K., Min, J.S., Lee, K.S., Yang, W.I., Kim, B.S. and Lee, K.B. (1991) Expression of Prognostic Factors (EGFR, ER) by Immunohistochemical Staining Method in Male Breast Cancer. Yonsei Medical Journal, 32, 126-130.

[186]   Park, S., Kim, J.H., Koo, J., Park, B.W. and Sik Lee, K. (2008) Clinicopathological Characteristics of Male Breast Cancer. Yonsei Medical Journal, 49, 978-986.

[187]   Liu, D., Xie, G. and Chen, M. (2013) Clinicopathologic Characteristics and Survival of Male Breast Cancer. International Journal of Clinical Oncology, 19(2), 280-287.

[188]   Chen, X.Y., Liu, X.D., Zhang, L., Li, S.F., Shi, Y.H. and Tong, Z.S. (2013) Poorer Survival of Male Breast Cancer Compared with Female Breast Cancer Patients May Be Due to Biological Differences. Japanese Journal of Clinical Oncology, 43, 954-963.

[189]   Baojiang, L., Tingting, L., Gang, L. and Li, Z. (2012) Male Breast Cancer: A Retrospective Study Comparing Survival with Female Breast Cancer. Oncology Letters, 4, 642-646.

[190]   Rai, B., Ghoshal, S. and Sharma, S.C. (2005) Breast Cancer in Males: A PGIMER Experience. Journal of Cancer Research and Therapeutics, 1, 31-33.

[191]   El-Beshbeshi, W. and Abo-Elnaga, E.M. (2012) Male Breast Cancer: 10-Year Experience at Mansoura University Hospital in Egypt. Cancer Biology & Medicine, 9, 23-28.

[192]   Ahmed, A., Ukwenya, Y., Abdullahi, A. and Muhammad, I. (2012) Management and Outcomes of Male Breast Cancer in Zaria, Nigeria. International Journal of Breast Cancer, 2012, Article ID: 845143.

[193]   Ihekwaba, F.N. (1994) Breast Cancer in Men in Black Africa: A Report of 73 Cases. Journal of the Royal College of Surgeons of Edinburgh, 39, 344-347.

[194]   Vaizey, C., Burke, M. and Lange, M. (1999) Carcinoma of the Male Breast—A Review of 91 Patients from the Johannesburg Hospital Breast Clinics. South African Journal of Surgery, 37, 6-8.

[195]   Kiluk, J.V., Lee, M.C., Park, C.K., Meade, T., Minton, S., Harris, E., Kim, J. and Laronga, C. (2011) Male Breast Cancer: Management and Follow-Up Recommendations. Breast Journal, 17, 503-509.